G/A1947 polymorphism in catechol‐O‐methyltransferase (COMT) gene in Parkinson's disease
暂无分享,去创建一个
[1] I. Ulmanen,et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.
[2] T. Kiviluoto,et al. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European Journal of Biochemistry.
[3] A. Jalanko,et al. Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA , 1991 .
[4] Z Dembic,et al. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Weinshilboum,et al. Human liver catechol‐O‐methyltransferase pharmacogenetics , 1990, Clinical pharmacology and therapeutics.
[6] L. Rivera-calimlim,et al. Difference in erythrocyte catechol‐O‐methyltransferase activity between Orientals and Caucasians: Difference in levodopa tolerance , 1984, Clinical pharmacology and therapeutics.
[7] Y. Cheng,et al. Metabolism and mechanism of action of 5-fluorouracil. , 1990, Pharmacology & therapeutics.